Get started
Work

Supplementary Methods S1 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors

Year: 2024
Type: supplementary-materials
Abstract: Supplemental Materials and Methods concerning patient samples, cell lines, tissue culture, iMALDI-MS, Nano-LC-Orbitrap-MS, LC-MRM-MS
DOI: 10.1158/2767-9764.26553471
Authors: Constance A. Sobsey, Bjoern C. Froehlich, Georgia Mitsa, Sahar Ibrahim, Robert Popp, Rene P. Zahedi, Elza C. de Bruin, Christoph H. Borchers, Gerald Batist
Language: English
Open Access status: gold
OpenAlex ID: W4401554568
Cites: 15
Cited by:
Related to: 10